{"id":4228,"date":"2024-04-04T17:00:48","date_gmt":"2024-04-04T21:00:48","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/"},"modified":"2026-09-24T00:05:52","modified_gmt":"2026-09-24T04:05:52","slug":"gensight-biologics-annonce-son-calendrier-financier-pour-2024","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/","title":{"rendered":"GenSight Biologics annonce son calendrier financier pour 2024"},"content":{"rendered":"\n<strong>Paris, France, le 4 avril 2024<\/strong>, <strong>19h00 <\/strong>\u2013 GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2024.\n\n&nbsp;\n<table>\n<tbody>\n<tr>\n<td width=\"323\"><strong>Information<\/strong><\/td>\n<td width=\"278\"><strong>Date* <\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 1<sup>er<\/sup> trimestre 2024<\/td>\n<td width=\"278\">04 avril 2024<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Assembl\u00e9e G\u00e9n\u00e9rale des actionnaires<\/td>\n<td width=\"278\">29 mai 2024<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 2<sup>\u00e8me<\/sup> trimestre 2024<\/td>\n<td width=\"278\">23 juillet 2024<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">R\u00e9sultats financiers du 1<sup>er<\/sup> semestre 2024<\/td>\n<td width=\"278\">23 septembre 2024<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 3<sup>\u00e8me<\/sup> trimestre 2024<\/td>\n<td width=\"278\">24 octobre 2024<\/td>\n<\/tr>\n<tr>\n<td width=\"323\">Position de tr\u00e9sorerie du 4<sup>\u00e8me<\/sup> trimestre 2024<\/td>\n<td width=\"278\">23 janvier 2025<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<em>* Ce calendrier financier est donn\u00e9 \u00e0 titre indicatif, sous r\u00e9serve de modifications. Le calendrier financier \u00e0 jour de la Soci\u00e9t\u00e9 est disponible sur son site Internet.<\/em>\n","protected":false},"excerpt":{"rendered":"<p>Paris, France, le 4 avril 2024, 19h00 \u2013 GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2024. &nbsp; Information Date* Position de tr\u00e9sorerie [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[79],"news-type":[76,80],"post-year":[],"class_list":["post-4228","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-company-and-personnel","news-type-corporate","news-type-finance"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le 4 avril 2024, 19h00 \u2013 GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2024. &nbsp; Information Date* Position de tr\u00e9sorerie [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-04T21:00:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:52+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"GenSight Biologics annonce son calendrier financier pour 2024\",\"datePublished\":\"2024-04-04T21:00:48+00:00\",\"dateModified\":\"2026-09-24T04:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/\"},\"wordCount\":138,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/\",\"name\":\"GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2024-04-04T21:00:48+00:00\",\"dateModified\":\"2026-09-24T04:05:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/04\\\/04\\\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics annonce son calendrier financier pour 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics","og_description":"Paris, France, le 4 avril 2024, 19h00 \u2013 GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui son calendrier financier pour 2024. &nbsp; Information Date* Position de tr\u00e9sorerie [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/","og_site_name":"GenSight Biologics","article_published_time":"2024-04-04T21:00:48+00:00","article_modified_time":"2026-09-24T04:05:52+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"GenSight Biologics annonce son calendrier financier pour 2024","datePublished":"2024-04-04T21:00:48+00:00","dateModified":"2026-09-24T04:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/"},"wordCount":138,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/","name":"GenSight Biologics annonce son calendrier financier pour 2024 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2024-04-04T21:00:48+00:00","dateModified":"2026-09-24T04:05:52+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/04\/04\/gensight-biologics-annonce-son-calendrier-financier-pour-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics annonce son calendrier financier pour 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4228"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4228\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4228"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4228"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4228"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4228"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}